Incyte board member Susanne Schaffert to step down in April

Incyte Corporation announced that board member Susanne Schaffert will resign effective April 15, 2026. Her departure is not due to disagreements. Incyte has seen significant financial momentum, with shares returning 49% over the past year, while also facing mixed analyst reactions regarding its drug pipeline, particularly for povorcitinib and products Opzelura and Jakafi.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin